Approved immune checkpoint inhibitors in hepatocellular carcinoma: a large-scale meta-analysis and systematic review.
Journal Information
Full Title: J Cancer Res Clin Oncol
Abbreviation: J Cancer Res Clin Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of interestAll authors have no competing interests. All authors have no relevant financial or non-financial interests to disclose. Conflict of interest All authors have no competing interests. All authors have no relevant financial or non-financial interests to disclose."
"Funding This study was supported by the National natural science foundation of china (82060388), (Science and Technology Department of Guizhou Province (QKHJC-ZK[2021]-YB396), Education Department of Guizhou Provincial (QJJ[2022]204), and Guizhou department and platform talents ([2018]5766–01), Science and Technology Bureau of Guiyang (ZKHT[2022]-4-3)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025